Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125530541 | 12553054 | 1 | I | 20130610 | 20160713 | 20160713 | EXP | IN-PFIZER INC-2013183783 | PFIZER | SHAH, I.. ANTIRETROVIRALS.. REACTIONS WEEKLY. 2013 | 2.00 | YR | M | Y | 28.00000 | KG | 20160713 | OT | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125530541 | 12553054 | 1 | PS | NELFINAVIR MESILATE | NELFINAVIR MESYLATE | 1 | Unknown | 1250 MG IN 3 DIVIDED DOSES | U | 20779 | |||||||||
| 125530541 | 12553054 | 2 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | 150 MG IN IN TWO DIVIDED DOSES | U | 0 | |||||||||
| 125530541 | 12553054 | 3 | SS | STAVUDINE. | STAVUDINE | 1 | Unknown | 30 MG IN TWO DIVIDED DOSES | U | 0 | |||||||||
| 125530541 | 12553054 | 4 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Unknown | 180 MG IN 2 DIVIDED DOSES | U | 0 | |||||||||
| 125530541 | 12553054 | 5 | SS | DIDANOSINE. | DIDANOSINE | 1 | Unknown | 125 MG, 1X/DAY | U | 0 | 125 | MG | QD | ||||||
| 125530541 | 12553054 | 6 | SS | EMTRICITABINE | EMTRICITABINE | 1 | Unknown | 150 MG, UNK | U | 0 | 150 | MG | |||||||
| 125530541 | 12553054 | 7 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | 80 MG IN TWO DIVIDED DOSES | U | 0 | |||||||||
| 125530541 | 12553054 | 8 | SS | LOPINAVIR W/RITONAVIR | LOPINAVIRRITONAVIR | 1 | Unknown | 300 MG, 2X/DAY | U | 0 | 300 | MG | BID | ||||||
| 125530541 | 12553054 | 9 | SS | TENOFOVIR | TENOFOVIR | 1 | Unknown | 225 MG, 1X/DAY | U | 0 | 225 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125530541 | 12553054 | 1 | HIV infection |
| 125530541 | 12553054 | 2 | HIV infection |
| 125530541 | 12553054 | 3 | HIV infection |
| 125530541 | 12553054 | 4 | HIV infection |
| 125530541 | 12553054 | 5 | HIV infection |
| 125530541 | 12553054 | 6 | HIV infection |
| 125530541 | 12553054 | 7 | HIV infection |
| 125530541 | 12553054 | 8 | HIV infection |
| 125530541 | 12553054 | 9 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125530541 | 12553054 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125530541 | 12553054 | Drug resistance | |
| 125530541 | 12553054 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125530541 | 12553054 | 1 | 200309 | 0 | ||
| 125530541 | 12553054 | 2 | 2001 | 0 | ||
| 125530541 | 12553054 | 3 | 200309 | 0 | ||
| 125530541 | 12553054 | 4 | 200106 | 0 | ||
| 125530541 | 12553054 | 5 | 200309 | 0 | ||
| 125530541 | 12553054 | 6 | 201010 | 0 | ||
| 125530541 | 12553054 | 7 | 200106 | 0 | ||
| 125530541 | 12553054 | 8 | 201010 | 0 | ||
| 125530541 | 12553054 | 9 | 201010 | 0 |